Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2018 16:30 ET | Source: Adamas Pharmaceuticals, Inc.

Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI™

EMERYVILLE, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
August 02, 2018 16:01 ET | Source: Adamas Pharmaceuticals, Inc.

Adamas Reports Second Quarter 2018 Financial Results

- GOCOVRI™ (amantadine) extended release capsules product sales reached $7.6 million for the second quarter - EMERYVILLE, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc....